Financial Results Overview (Figures in ₹ lakhs)

Quarter Ended September 30, 2026 (Unaudited):

  • Revenue from Operations: ₹6.65
  • Total Income: ₹6.65
  • Total Expenses: ₹80.41
  • Loss Before Tax: (₹73.75)
  • Loss for the Period: (₹73.75)
  • Basic and Diluted EPS: (₹0.14) per share of ₹10 face value

Comparative Quarterly Performance:

  • June 30, 2026 (Audited): Loss of ₹42.37 lakh
  • September 30, 2025 (Unaudited): Loss of ₹69.52 lakh

Half Year Ended September 30, 2026 (Unaudited):

  • Revenue from Operations: ₹11.66
  • Total Income: ₹12.79
  • Loss Before Tax: (₹116.12)
  • Loss for the Period: (₹116.11)
  • Basic and Diluted EPS: (₹0.21)

Year Ended March 31, 2026 (Audited):

  • Revenue from Operations: ₹20.97
  • Total Income: ₹45.02
  • Loss Before Exceptional Items: (₹440.55)
  • Exceptional Items: (₹427.73)
  • Loss Before Tax: (₹868.29)
  • Loss for the Year: (₹868.29)
  • Basic and Diluted EPS: (₹1.61)

Expense Breakdown (Quarter Ended September 30, 2026)

  • Employee Benefits Expense: ₹11.35
  • Finance Costs: ₹29.87
  • Depreciation and Amortization: ₹19.94
  • Other Expenses: ₹14.23
  • Purchase of Stock-In-Trade: ₹5.03

Balance Sheet Position (As at September 30, 2026)

Assets:

  • Total Assets: ₹4,255.10 lakh
  • Non-Current Assets: ₹337.78 lakh (Property, Plant & Equipment: ₹250.44 lakh)
  • Current Assets: ₹3,917.33 lakh (Inventories: ₹3,803.00 lakh; Trade Receivables: ₹97.65 lakh; Cash & Cash Equivalents: ₹11.41 lakh)

Liabilities and Equity:

  • Equity Share Capital: ₹5,401.48 lakh (face value ₹10 per share)
  • Other Equity: (₹4,572.17) lakh
  • Total Equity: ₹829.31 lakh
  • Non-Current Liabilities: ₹38.15 lakh
  • Current Liabilities: ₹3,387.64 lakh (Borrowings: ₹573.85 lakh; Trade Payables: ₹2,372.90 lakh; Provisions: ₹427.73 lakh)

Cash Flow Statement (Year Ended September 30, 2026)

  • Net Cash from Operating Activities: ₹32.68 lakh
  • Net Cash from Investing Activities: ₹0.00
  • Net Cash from Financing Activities: ₹20.99 lakh
  • Net Increase in Cash: ₹53.67 lakh
  • Cash at Beginning: ₹3,550.73 lakh
  • Cash at End: ₹3,604.40 lakh

Critical Notes and Qualifications

1. Inventory Valuation Concern: The inventory includes discount coupon vouchers amounting to ₹38.03 crore (₹3,803 lakh) that have remained unutilized due to closure of the company's main hospital operations. The management states these will be utilized/sold upon revival of operations and continue to be carried at book value.

2. Auditor Qualification: The statutory auditors (Rafik and Associates) issued a qualified opinion regarding these vouchers, noting that necessary shareholder approval for transfer to a related party had not been received as of September 30, 2026. They are unable to comment on the realizable value, appropriateness of book value carrying amount, or consequential financial impact due to prolonged closure and absence of definitive revival timeframe.

3. Ransomware Attack: The company suffered a ransomware attack on January 30, 2026, which corrupted certain data. Financial information has been reconstructed based on available records, with strengthened controls implemented. Management believes the impact has been appropriately considered to the extent ascertainable.

4. Segment Reporting: The company operates only in one segment - Healthcare Services.

5. Taxation: No current tax, deferred tax, or earlier year tax expenses were recorded for any period presented.